Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00772707 · ClinicalTrials.gov registry record · NA
A Multi-Center Investigation of Patient Acceptability of OPTI-FREE RepleniSH® Multi-Purpose Disinfecting Solution (MPDS)
A NA study of Myopia, sponsored by Alcon Research.
- Completed
- Registry status
- NA
- Development phase
- 114
- Enrollment target
- 1
- Study location
NCT00772707: Completed NA study of Myopia, sponsored by Alcon Research.
NCT00772707 is a NA study of Myopia that has completed, run by Alcon Research. The registered enrollment target is 114 participants, below the 267-participant average among 90 other Myopia trials with a reported enrollment target (57% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00772707, a NA study of Myopia, has completed, sponsored by Alcon Research.
- COMPLETED
- Registry status
- NA
- Development phase
- 114 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study was to demonstrate that current successful fulltime daily wear soft contact lens wearers using competitive multi-purpose solutions will note improved comfort when using OPTI-FREE RepleniSH®.
Primary Outcome
Prior to any ocular assessments at the visit, comfort ratings were collected on a questionnaire using 5-point Likert scale, with 1=Strongly Agree, 1=Agree, 3=Neutral, 4=Disagree, 5=Strongly Disagree. The percentage of participants responding with "Strongly Agree" or "Agree" for each question is presented.
Conditions Studied
Interventions
- DEVICE Multi-Purpose Disinfecting Solution (OPTI-FREE RepleniSH)
- DEVICE Contact Lenses
Study Locations (1)
Texas
- Alcon Call Center for Trial Locations - Fort Worth
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 114 participants |
| Start Date | 2008-09 |
| Est. Completion | 2008-10 |
| Phase | NA |
What the finished NCT00772707 record still lists
NCT00772707 is an interventional study that assigns participants to a tested intervention. The registered 114 participants enrollment target is mid-sized for trials with a published cap, below the 267-participant average among 90 other Myopia trials with a reported enrollment target (57% lower).
The record links to 1 condition, with Myopia appearing as the primary indexed condition, and to 2 interventions - of which Multi-Purpose Disinfecting Solution (OPTI-FREE RepleniSH) is the first listed.
NCT00772707 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT00772707 about?
NCT00772707 is a clinical study titled "A Multi-Center Investigation of Patient Acceptability of OPTI-FREE RepleniSH® Multi-Purpose Disinfecting Solution (MPDS)". The purpose of this study was to demonstrate that current successful fulltime daily wear soft contact lens wearers using competitive multi-purpose solutions will note improved comfort when using OPTI-FREE RepleniSH®.
What is the current status of trial NCT00772707?
This trial is currently completed. It is a NA study. The enrollment target is 114 participants. The study started on 2008-09. Estimated completion is 2008-10.
What conditions does trial NCT00772707 study?
This clinical trial studies the following conditions: Myopia.
What interventions are being tested in trial NCT00772707?
The interventions under investigation include: Multi-Purpose Disinfecting Solution (OPTI-FREE RepleniSH) (DEVICE), Contact Lenses (DEVICE).
Who is sponsoring clinical trial NCT00772707?
This trial is sponsored by Alcon Research, which has 275 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00772707 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Myopia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00772707's enrollment target sits among peer trials
114 35th of 90 higher than 56 of 90 other Myopia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Myopia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Efficacy of Repeated Low-level Red-light Therapy in Myopia Control
RECRUITING · NA
-
Comprehensive Assessment of Multiple Products (CAMP)
RECRUITING · NA
-
Children's Viewing Behavior
RECRUITING · NA
-
Violet Light for the Suppression of Myopia
RECRUITING · NA
-
Measuring Outcomes of LASIK and EVO-ICL in Matched Populations
RECRUITING · NA
-
Wavelength Intervention for Nearsighted Kids
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04522791 · 114 participants · Phase 2
Breathing, Relaxation, Attention Training, & Health in Older Adults (BREATHE)
- NCT04875052 · 114 participants · NA
Vibration and Post-traumatic Osteoarthritis Risk Following ACL Injury
- NCT05100342 · 114 participants
Prospective Validation of a Points Score System Predicting 30-day Survival
- NCT05224089 · 114 participants · Phase 4
Bilateral TAP and RS Blocks Using Liposomal Bupivacaine/Bupivacaine vs. Regular Bupivacaine in Laparoscopic Colectomy
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia